Skip to main content
Loading

Analytical method transfer: robust assays, reproducibility, and tech transfer pitfalls

04 May 2026
Cell Therapy Manufacturing
  • How can we ensure an analytical method is truly robust across different labs, instruments, and operators?
  • What factors most commonly undermine reproducibility during method transfer, and how can they be proactively controlled?
  • Which validation parameters (e.g., accuracy, precision, specificity) are most critical to reassess during a tech transfer?
  • What are the most frequent pitfalls in method transfer, and how can they be identified early in the process?
  • How can communication, documentation, and training be optimized to ensure a smooth and successful analytical method transfer?
Industry Expert
Yu Qian, Director, Cell Therapy Analytical Development - Novartis